Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Buys Automated Lab Technologies Company Velocity11

NEW YORK (GenomeWeb News) – Agilent Technologies said yesterday that it has inked a deal to buy Velocity11, a private life science lab technology company, for an undisclosed sum.
Agilent believes the acquisition will strengthen its automated sample-preparation offerings across a broad range of applications.
Velocity11 designs, makes, and markets robotic solutions including stand-alone, bench-top, and multi-armed robotic systems. The company also markets software designed to control the robotics in its products.
Agilent said it would offer jobs to “substantially all of Velicity11’s approximately 150 employees worldwide.”
Velocity11 is based in Menlo Park, Calif., with a second office in Melbourn, Hertfordshire, UK, and has field sales and support “throughout the US and Western Europe.”
Nick Roelofs, Agilent's VP of life science systems and solutions, said the acquisition will help the firm offer automated solutions that can “speed drug discovery and genetic research.”
Financial terms of the agreement were not released.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more